Monoclonal antibody to SARS-CoV-2 Spike RBD
R1-158-100
Datasheet as| Name | Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27C2 |
| Immunogen | SARS-CoV-2 virus |
| Immunogen Description | SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies discovered by using HybriFree Technology) |
| Clonality | Recombinant human monoclonal |
| Clone | 27C2 |
| Class | Human IgG1-lambda |
| Reactivity | SARS-CoV-2 Spike RBD |
| Dissociation constant (KD) | < 1.0 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein)
6.58 x 10-9 M (measured against SARS-CoV-2 Spike S1 protein) |
| Application | ELISA |
| Protocol | Indirect ELISA 0.02 – 0.04 ng/ml |
| Purification | Protein A affinity chromatography following desalting |
| Buffer | PBS pH 7.4 |
| Unit Size | 100 µg |
| Shipping | Shipped on dry ice |
| Storage | Store at -20 °C to -70 °C long term. Avoid multiple freeze-thaw cycles. |
| Limitations | This product is for research use only. |
Buy now
€300 / 100µg
€500 / 500µg
€745 / 1000µg
custom quantity - ask quotation
Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Spike
RBD, clone 27C2. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27C2 (-DTT). Lane 2. Size Marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Spike RBD,
clone 27C2 (+DTT). Lane 4. Size Marker
RBD, clone 27C2. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Spike RBD, clone 27C2 (-DTT). Lane 2. Size Marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Spike RBD,
clone 27C2 (+DTT). Lane 4. Size Marker